Theravance Biopharma (TBPH) Gross Profit Growth (3y) (2016 - 2018)
Theravance Biopharma (TBPH) Gross Profit Growth (3y) (2016 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 80.64% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Theravance Biopharma | 864.82 Mn | 470.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 179.47% |
| Sep 30, 2018 | 6.24% |
| Jun 30, 2018 | 49.23% |
| Mar 31, 2018 | -27.95% |
| Dec 31, 2017 | 47.94% |
| Sep 30, 2017 | -18.00% |
| Jun 30, 2017 | -7.33% |
| Mar 31, 2017 | 49.35% |
| Dec 31, 2016 | 196.16% |
| Sep 30, 2016 | 820.89% |
| Jun 30, 2016 | 1,321.50% |
| Mar 31, 2016 | 828.88% |